FedEx Express and TNT are launching their clinical trial solution, Medpak VI°C, a service first launched in Europe, globally starting with Asia-Pacific and North America.
Medpak VI°C – offering safe and reliable transportation of sensitive healthcare products – originally a TNT product, was first launched in Europe in 2016 and made available to FedEx customers in Europe in 2018.
Now being rolled out globally – first with Asia-Pacific and North America – Medpak VI°C is a network solution that allows companies in the clinical trials sector to ship test medications in temperature-controlled, reuseable packaging.
Marking a significant development for the FedEx Express healthcare business, Medpak VI°C is also now serving customers in the pharmaceutical and medical device industries in addition to the clinical trials sector. These sectors all rely on excellence in temperature controlled technology to ship high-value and temperature-sensitive products.
“The international launch of Medpak VI°C to various healthcare sectors marks an important and exciting step forward for the FedEx Express and TNT healthcare portfolio, as well as for integration of the two businesses,” says Roland Schütze, Healthcare Lead at FedEx Express and TNT.
“More than anything, our customers need reliability in terms of the technology itself, highly accurate delivery performance, time-sensitive shipment and having a partner that can deliver a full end-to-end service without multiple carriers and supported by a dedicated customer service team. I’m delighted that we’re able to take this innovation to the global marketplace.”
FedEx Express and TNT began integrating in 2016 to offer customers a broader service portfolio and the benefits of access to the world’s largest air express network and an unparalleled road network.